首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   211824篇
  免费   13538篇
  国内免费   578篇
耳鼻咽喉   2570篇
儿科学   6917篇
妇产科学   4713篇
基础医学   29208篇
口腔科学   7978篇
临床医学   17060篇
内科学   46527篇
皮肤病学   5166篇
神经病学   19366篇
特种医学   6315篇
外国民族医学   26篇
外科学   24809篇
综合类   1749篇
现状与发展   1篇
一般理论   118篇
预防医学   22762篇
眼科学   3696篇
药学   13065篇
中国医学   758篇
肿瘤学   13136篇
  2023年   1386篇
  2022年   1192篇
  2021年   5470篇
  2020年   3629篇
  2019年   5074篇
  2018年   6725篇
  2017年   4907篇
  2016年   4789篇
  2015年   5501篇
  2014年   7306篇
  2013年   9304篇
  2012年   14604篇
  2011年   15077篇
  2010年   7608篇
  2009年   6791篇
  2008年   11407篇
  2007年   11982篇
  2006年   11198篇
  2005年   11292篇
  2004年   10510篇
  2003年   9549篇
  2002年   7324篇
  2001年   5128篇
  2000年   5078篇
  1999年   4542篇
  1998年   1878篇
  1997年   1532篇
  1996年   1286篇
  1995年   1237篇
  1994年   1186篇
  1993年   1077篇
  1992年   2709篇
  1991年   2620篇
  1990年   2385篇
  1989年   2384篇
  1988年   2148篇
  1987年   1987篇
  1986年   1860篇
  1985年   1781篇
  1984年   1295篇
  1983年   1047篇
  1982年   596篇
  1981年   549篇
  1980年   519篇
  1979年   935篇
  1978年   615篇
  1977年   492篇
  1975年   550篇
  1974年   539篇
  1973年   547篇
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
1.
2.
3.
4.
5.
6.
7.
We present data from patients with advanced biliary tract cancer (BTC) receiving pembrolizumab in the KEYNOTE-158 (NCT02628067; phase 2) and KEYNOTE-028 (NCT02054806; phase 1b) studies. Eligible patients aged ≥18 years from both studies had histologically/cytologically confirmed incurable BTC that progressed after standard treatment regimen(s), measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, Eastern Cooperative Oncology Group performance status 0/1, and no prior immunotherapy. Programmed death ligand 1 (PD-L1)-positive tumors were required for eligibility in KEYNOTE-028 only. Patients received pembrolizumab 200 mg every three weeks (KEYNOTE-158) or 10 mg/kg every two weeks (KEYNOTE-028) for ≤2 years. Primary efficacy endpoint was objective response rate (ORR) by RECIST v1.1. Response assessed by independent central review is reported. KEYNOTE-158 enrolled 104 patients and KEYNOTE-028 enrolled 24 patients. Median (range) follow-up was 7.5 months (0.6-34.3) in KEYNOTE-158 and 5.7 months (0.6-55.4) in KEYNOTE-028. In KEYNOTE-158, ORR was 5.8% (6/104; 95% CI, 2.1%-12.1%); median duration of response (DOR) was not reached (NR) (range, 6.2-26.6+ months). Median (95% CI) OS and PFS were 7.4 (5.5-9.6) and 2.0 (1.9-2.1) months. Among PD-L1-expressers (n = 61) and PD-L1-nonexpressers (n = 34), respectively, ORR was 6.6% (4/61) and 2.9% (1/34). In KEYNOTE-028, ORR was 13.0% (3/23; 95% CI, 2.8%-33.6%); median DOR was NR (range, 21.5-53.2+ months). Median (95% CI) OS and PFS were 5.7 (3.1-9.8) and 1.8 (1.4-3.1) months. Grade 3 to 5 treatment-related adverse events occurred in 13.5% of patients in KEYNOTE-158 (no grade 4; grade 5 renal failure, n = 1) and 16.7% in KEYNOTE-028 (no grade 4/5). In summary, pembrolizumab provides durable antitumor activity in 6% to 13% of patients with advanced BTC, regardless of PD-L1 expression, and has manageable toxicity.  相似文献   
8.
Neorickettsia helminthoeca (NH), the agent of salmon poisoning disease or canine neorickettiosis (CN), is a bacterial endosymbiont of the nematode Nanophyetus salmincola, and infections are spreading among specific fish‐eating mammalians. This article describes the pathologic and immunohistochemical findings associated with spontaneous NH‐induced infections in dogs from Southern Brazil. The principal pathologic findings were hypertrophy of Peyer patches and lymphadenopathy with lymphocytic proliferation, chronic interstitial pneumonia, and chronic enteritis associated with positive intralesional immunoreactivity to antigens of NH within macrophages and histiocytes. Positive immunoreactivity against canine parvovirus‐2 (CPV‐2) or/and canine distemper virus was not detected in the evaluated intestinal segments or in the samples from the cerebellum and lungs, respectively, from the dogs evaluated. These findings demonstrated that NH was involved in the enteric, pulmonary, and lymphoid lesions herein described, and provide additional information to confirm the occurrence of this bacterial endosymbiont within this geographical location. It is proposed that chronic pneumonia should be considered as a pathologic manifestation of NH‐induced infections. Additionally, our results show that the occurrences of CN seem to be underdiagnosed in Southern Brazil due to the confusion with the incidence of CPV‐2.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号